StockData
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. (CGEM) stock

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.28−0.22 (-2.37%)

Close on Nov 17, 2026Market cap $596.89MP/E –Yield –

Cullinan Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Cullinan Therapeutics's profit margin for the twelve months ending Dec 31, 2021 was -346.1%. For fiscal 2021 it was -346.1%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021-346.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2021Mar 31, 2021-0.4%–

More Cullinan Therapeutics figures

See a number that looks wrong?